Lymphoma

Latest News

3 Things You Should Know About Adverse Events With Targeted Therapies for DLBCL
3 Things You Should Know About Adverse Events With Targeted Therapies for DLBCL

February 20th 2025

Tips from experts on how to think about and manage adverse events in patients with diffuse large B-cell lymphoma.

Study Finds Recent Falls, Inability to Balance on Left Leg Indicate OS Decrease in NHL
Study Finds Recent Falls, Inability to Balance on Left Leg Indicate OS Decrease in NHL

February 18th 2025

Advancing the MZL Landscape Through the MZL Workshop
Advancing the MZL Landscape Through the MZL Workshop

February 18th 2025

Age Did Not Negatively Impact Response From CAR T-Cell Therapy in R/R LBCL
Age Did Not Negatively Impact Response From CAR T-Cell Therapy in R/R LBCL

February 18th 2025

The safety profile of ibrutinib/venetoclax in the phase 3 SYMPATICO trial was consistent with the known profiles for each individual agent.
Venetoclax/Ibrutinib Significantly Improves PFS in Mantle Cell Lymphoma

February 18th 2025